![](/img/cover-not-exists.png)
PCV21 A BENEFIT-RISK ASSESSMENT OF USING CYP2C19 GENOTYPE INFORMATION TO GUIDE ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME
GF Guzauskas, D Veenstra, D HughesVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72741-8
File:
PDF, 97 KB
english, 2010